Neurosense Therapeutics News - September 2026
🟢 Neurosense Therapeutics is trading 9.56% up today after HC Wainwright initiated Buy-rated coverage
Neurosense Therapeutics is trading 9.56% up now at $0.44 after HC Wainwright initiated coverage on September 3, 2026, with a Buy rating and an $8.00 price...
🟢 Neurosense Therapeutics is trading 8.69% up today after HC Wainwright initiated Buy-rated coverage
Neurosense Therapeutics is trading 8.69% up now at $0.45 after HC Wainwright initiated coverage on September 3, 2026, with a Buy rating and an $8.00 price...
🟢 Neurosense Therapeutics is trading 12% up in pre-market after HC Wainwright initiated Buy-rated coverage
Neurosense Therapeutics is trading 11.93% up at $0.46 after HC Wainwright & Co. initiated coverage on September 3, 2026, with a Buy rating and an $8.00 price...
🟢 Neurosense Therapeutics Surges in Pre-Market on HC Wainwright & Co. 'Buy' Rating and Redesigned PrimeC ALS Strategy
- Neurosense Therapeutics is trading 7.32% up in pre-market at $0.44 following HC Wainwright & Co. initiating coverage with a 'Buy' rating and an $8.00 price...